Newsroom

Press releases

SEPTEMBER 16, 2026
Kowa Pharmaceuticals America Announces K-911 Data Presentations at American Academy of Optometry 2026 Annual Meeting
Read More
AUGUST 27, 2026
Kowa Pharmaceuticals America Announces FDA Acceptance of New Drug Application for K-911, an Investigational IOP-Lowering Eye Drop for Patients with Open-Angle Glaucoma or Ocular Hypertension
Read More
JULY 1, 2026
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment
Read More

NCX 470 Phase 3 Efficacy and Safety — Poster Presentation
Read More
Mechanisms of Optic Nerve Protection in Glaucoma — Review Article
Read More
Comparative Efficacy of Novel IOP-Lowering Agents in Open-Angle Glaucoma
Read More